Gynositol Méno
Food supplement declared in France
Gynositol Méno is a food supplement declared in France. Status: retiré du marché le 6 June 2025. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- Besins Healthcare France
- Status
- Retiré du marché le 6 June 2025
- Form
- Sachet
- Daily dose
- 1 sachet
- Directions for use
- 1 sachet par jour à dissoudre dans la bouche ou à diluer dans un verre d’eau.
- Intended populations
- Personnes de plus de 60 ans, Femme
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Ménopause
Declaration 1198, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 6 June 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Substances
| Name | Per day |
|---|---|
| resvératrol | 50 mg |
Other active ingredients
| Name | Per day |
|---|---|
| D-chiro inositol | not declared |
| Myo-inositol | not declared |
Micro-organisms
| Strain | Per day |
|---|---|
| Bifidobacterium Animalis CECT8145 | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
Additives
E551
Other ingredients
maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
• Déconseillé chez la femme enceinte et allaitante. • Déconseillé en cas d'allergie à l’un des composants. • Lire attentivement la notice avant toute utilisation. • Ne pas dépasser la dose journalière recommandée. • L’usage prolongé est déconseillé. • Tenir hors de portée des enfants de moins de 12 ans
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.